GlassScriptPhysician profile
Tobin M Speight
NPI 1811392533
$34,567.34
in general payments reported to CMS, 2019-2025
23 companies · $6,319 in 2025
The $6,319 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $8,329 · 2023: $4,715 · 2024: $4,812 · 2025: $6,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,500.00 |
| Food and Beverage | $3,345.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32,494.19 | 2021-2025 | Lifevest |
| Abiomed | $277.93 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $254.31 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $239.11 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $212.07 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Itamar Medical INC | $148.04 | 2021-2025 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.62 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $97.74 | 2021-2025 | Farxiga, Brilinta |
| Alnylam Pharmaceuticals INC. | $92.37 | 2025 | Amvuttra, Onpattro |
| Pfizer INC. | $87.90 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.15 | 2024-2025 | Livtencity |
| Scpharmaceuticals INC. | $78.78 | 2024-2025 | |
| Analog Devices INC. | $72.64 | 2025 | Sensinel Cpm Wearable |
| Daiichi Sankyo INC. | $57.84 | 2023-2024 | Injectafer |
| Amgen INC. | $43.30 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $36.08 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $31.26 | 2022 | |
| Edwards Lifesciences Corporation | $28.40 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $28.20 | 2024 | Latitude Communicator Power Supply |
| Cvrx, INC. | $21.56 | 2023 | Barostim Neo System |
| Invivyd INC | $20.31 | 2024 | Pemgarda |
| Bayer Healthcare Pharmaceuticals INC. | $17.13 | 2025 | |
| Exact Sciences Corporation | $15.41 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tobin Speight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.